Vigil Neuroscience, Inc. - Common Stock (VIGL)

CUSIP: 92673K108

Q2 2022 13F Holders as of 30 Jun 2022

Type / Class
Equity / Common Stock
Shares outstanding
46,698,729
Total 13F shares
17,327,215
Share change
-529,999
Total reported value
$44,584,000
Price per share
$2.58
Number of holders
30
Value change
-$2,589,017
Number of buys
9
Number of sells
30

Quarterly Holders Quick Answers

What is CUSIP 92673K108?
CUSIP 92673K108 identifies VIGL - Vigil Neuroscience, Inc. - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Top shareholders of VIGL - Vigil Neuroscience, Inc. - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
Atlas Venture Life Science Advisors, LLC
13F
Company
12%
5,836,874
$41,033,000 31 Mar 2022
13F
Northpond Ventures, LLC
13F
Company
9%
4,214,498
$29,628,000 31 Mar 2022
13F
Vida Ventures GP III, L.L.C.
3/4/5
10%+ Owner
class O/S missing
5,015,929
$18,809,734 11 Jan 2022
Northpond Ventures GP, LLC
3/4/5
10%+ Owner
class O/S missing
4,214,498
$15,804,368 11 Jan 2022
CITADEL ADVISORS LLC
13F
Company
4.6%
2,162,639
$14,883,000 31 Mar 2022
13F
AMGEN INC
3/4/5
10%+ Owner
class O/S missing
3,206,281
$12,023,554 11 Jan 2022
Artal Group S.A.
13F
Company
2.4%
1,121,191
$7,882,000 31 Mar 2022
13F
Clay Thorp
3/4/5
Director
class O/S missing
1,559,030
$5,846,363 16 May 2022
Cormorant Asset Management, LP
13F 3/4/5
Company · Former 10% Owner
1.3%
616,786
$4,206,000 31 Mar 2022
Pivotal bioVenture Partners Investment Advisor LLC
13F
Company
1.2%
560,595
$3,941,000 31 Mar 2022
13F
Rock Springs Capital Management LP
13F
Company
1%
471,958
$3,318,000 31 Mar 2022
13F
ORBIMED ADVISORS LLC
13F
Company
0.88%
411,191
$2,891,000 31 Mar 2022
13F
Deep Track Capital, LP
13F
Company
0.83%
389,141
$2,736,000 31 Mar 2022
13F
VANGUARD GROUP INC
13F
Company
0.82%
385,198
$2,708,000 31 Mar 2022
13F
BlackRock Finance, Inc.
13F
Company
0.65%
303,689
$2,135,000 31 Mar 2022
13F
HARVARD MANAGEMENT CO INC
13F
Company
0.62%
289,460
$2,035,000 31 Mar 2022
13F
Logos Global Management LP
13F
Company
0.44%
205,595
$1,445,000 31 Mar 2022
13F
Alexandria Venture Investments, LLC
3/4/5
10%+ Owner
class O/S missing
192,973
$723,649 11 Jan 2022
BARCLAYS PLC
13F
Company
0.22%
102,773
$722,000 31 Mar 2022
13F
DAFNA Capital Management LLC
13F
Company
0.21%
99,754
$701,000 31 Mar 2022
13F
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
0.21%
97,080
$682,000 31 Mar 2022
13F
Squarepoint Ops LLC
13F
Company
0.18%
86,193
$606,000 31 Mar 2022
13F
CAAS CAPITAL MANAGEMENT LP
13F
Company
0.16%
75,000
$527,000 31 Mar 2022
13F
GOLDMAN SACHS GROUP INC
13F
Company
0.16%
73,839
$519,000 31 Mar 2022
13F
CITIGROUP INC
13F
Company
0.14%
64,094
$451,000 31 Mar 2022
13F
NORTHERN TRUST CORP
13F
Company
0.12%
56,683
$398,000 31 Mar 2022
13F
STATE STREET CORP
13F
Company
0.12%
54,479
$383,000 31 Mar 2022
13F
DAVIDSON KEMPNER CAPITAL MANAGEMENT LP
13F
Company
0.06%
30,000
$211,000 31 Mar 2022
13F
LMR Partners LLP
13F
Company
0.06%
27,642
$194,000 31 Mar 2022
13F
RENAISSANCE TECHNOLOGIES LLC
13F
Company
0.04%
20,041
$141,000 31 Mar 2022
13F
MILLENNIUM MANAGEMENT LLC
13F
Company
0.04%
19,930
$140,000 31 Mar 2022
13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC
13F
Company
0.04%
19,198
$135,000 31 Mar 2022
13F
Bank of New York Mellon Corp
13F
Company
0.03%
13,341
$94,000 31 Mar 2022
13F
Point72 Hong Kong Ltd
13F
Company
0.03%
12,667
$89,000 31 Mar 2022
13F
NEW YORK STATE COMMON RETIREMENT FUND
13F
Company
0.02%
8,500
$60,000 31 Mar 2022
13F
DEUTSCHE BANK AG\
13F
Company
0.01%
3,747
$26,000 31 Mar 2022
13F
AMERICAN INTERNATIONAL GROUP, INC.
13F
Company
0.01%
3,332
$23,000 31 Mar 2022
13F
JPMORGAN CHASE & CO
13F
Company
0.01%
3,148
$22,000 31 Mar 2022
13F
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM
13F
Company
0.01%
2,795
$20,000 31 Mar 2022
13F
AMALGAMATED BANK
13F
Company
0.01%
2,451
$17,000 31 Mar 2022
13F
Amalgamated Financial Corp.
13F
Company
0.01%
2,451
$17,000 31 Mar 2022
13F
Tower Research Capital LLC (TRC)
13F
Company
0%
1,773
$12,000 31 Mar 2022
13F
STRS OHIO
13F
Company
0%
1,600
$11,000 31 Mar 2022
13F
BANK OF AMERICA CORP /DE/
13F
Company
0%
1,519
$11,000 31 Mar 2022
13F
WELLS FARGO & COMPANY/MN
13F
Company
0%
1,465
$10,000 31 Mar 2022
13F
ROYAL BANK OF CANADA
13F
Company
0%
1,037
$7,000 31 Mar 2022
13F
Cubist Systematic Strategies, LLC
13F
Company
0%
1,000
$7,000 31 Mar 2022
13F
MORGAN STANLEY
13F
Company
0%
838
$7,000 31 Mar 2022
13F
UBS Group AG
13F
Company
0%
920
$6,000 31 Mar 2022
13F
Legal & General Group Plc
13F
Company
0%
634
$4,000 31 Mar 2022
13F

Institutional Holders of Vigil Neuroscience, Inc. - Common Stock (VIGL) as of Q2 2022

As of 30 Jun 2022, Vigil Neuroscience, Inc. - Common Stock (VIGL) was held by 30 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 17,327,215 shares. The largest 10 holders included Atlas Venture Life Science Advisors, LLC, Northpond Ventures, LLC, CITADEL ADVISORS LLC, Artal Group S.A., Cormorant Asset Management, LP, Pivotal bioVenture Partners Investment Advisor LLC, Rock Springs Capital Management LP, ORBIMED ADVISORS LLC, VANGUARD GROUP INC, and Deep Track Capital, LP. This page lists 30 institutional shareholders reporting positions in this security for the Q2 2022 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q2 2022 vs Q1 2022 Across Filers

Q1 2022 holders
47
Q2 2022 holders
30
Holder diff
-17
Investor Q1 2022 Shares Q2 2022 Shares Share Diff Share Chg % Q1 2022 Value $ Q2 2022 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.